Dr Mohamed Bouattour, Onco-hepatology (hepatocellular carcinoma, cholangiocarcinoma, rare liver cancers)

Specialty

Onco-hepatology (hepatocellular carcinoma, cholangiocarcinoma, rare liver cancers)

Hospital

Hôpital Beaujon (Clichy)

Latest articles

Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. (Oct 1, 2025)
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (Sep 1, 2025)
Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial. (Aug 1, 2025)
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (Aug 1, 2025)
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study. (Jun 4, 2025)